Type 2 & other diabetes

Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study

DiabetologiaPublished Metabolomics association study with causal mediation and two-sample Mendelian randomisation analyses

Authors' conclusion

Our findings identify known BCAAs and lipids, along with novel N-lactoyl-amino acid metabolites, significantly associated with prediabetes and diabetes, that mediate the effect of diabetes from baseline to follow-up (18 and 48 months). Causal inference using genetic variants shows the role of lipid metabolism and n-3 fatty acids as being causal for metabolite-to-type 2 diabetes whereas the sum of hexoses is causal for type 2 diabetes-to-metabolite. Identified metabolite markers are useful for stratifying individuals based on their risk progression and should enable targeted interventions.

Study context

Population
IMI-DIRECT consortium plasma samples; 911 metabolites (132 targeted, 779 untargeted) passed quality control3,000 plasma samples
Comparison
Glycaemic status: normal glucose regulation vs impaired glucose regulation/prediabetes vs T2D
Outcome
Metabolites significantly different between glycaemic groups (targeted; untargeted in parentheses)
Methodological detailstargeted and untargeted metabolomics, multivariable linear and logistic regression, Bonferroni corrected, causal mediation test, two-sample Mendelian randomisation (2SMR)
  • Targeted and untargeted metabolomics
  • Multivariable linear and logistic regression
  • Bonferroni corrected
  • Causal mediation test
  • Two-sample Mendelian randomisation (2SMR)

Main finding

As reported in the abstract

Normal glucose regulation vs impaired glucose regulation/prediabetes

4

15

Normal glucose regulation vs T2D

34

99

Impaired glucose regulation vs T2D

50

108

Further findings

Mediation of T2D and association with HbA1c progression rate · baseline to 18 and 48 months

Lysophosphatidylcholine a C17:0, sum of hexoses, BCAA-metabolism amino acids (leucine, isoleucine, valine, N-lactoylvaline, N-lactoylleucine, formiminoglutamate), lactate and unknown X-24295 associated with HbA1c progression rate and significant mediators of T2D

2SMR causal effects (UK Biobank GWAS summary statistics)

T2D causal effect on levels of hexose, glutamate and caproate [fatty acid (FA) 6:0]
PC aa C36:2, PC aa C36:5, PC ae C36:3, PC ae C34:3, stearidonate (18:4n3) and docosapentaenoate (22:5n3) potentially causal for development of T2D

Original publication

Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study. Diabetologia. Published 30 September 2024. doi:10.1007/s00125-024-06282-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.